With China's growing dominance in the biopharma R&D sector, a collection of g | A group of over 20 global pharma leaders met with Japan's Prime Minister Sanae Takaichi to address Japan's declining share of biopharma R&D.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…
Biopharma sales trended upward in the first quarter of this year as eight of the industry’s top-25 companies achieved…
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. |…
Pharma companies need to strengthen and modernize patient support programs to reflect rising rates of cancer in adults aged 18 to…
In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in…
